First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study
Short-term effect of gluten-free diet on disease severity, quality of life, and inflammatory markers among patients with mild to moderate ulcerative colitis: A triple-blind randomized placebo-controlled trial
Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn’s Disease: Results From the Phase 3 GRAVITI Study
Severe obesity, a susceptibility factor for developing inflammatory bowel disease: results of a population-based study